{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:17:49Z","timestamp":1787696269276,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Cardiovascular disease has become increasingly prevalent in the HIV population. Antiretroviral therapy and HIV itself independently increase the risk of dyslipidemia. While statins are currently the predominant therapy to treat dyslipidemia in HIV patients, drug\u2013drug interactions and adverse drug events can limit their use. Proprotein convertase subtilisin\/kexin type 9 inhibitors have shown promising results in preliminary trials by significantly reducing low density lipoprotein and other atherogenic lipid levels. They should be considered as an early intervention alongside statins in HIV patients with dyslipidemia.<\/jats:p>","DOI":"10.1097\/crd.0000000000000587","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T14:04:55Z","timestamp":1701266695000},"page":"112-113","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["PCSK9 Inhibitors\u2014A New Hope for Dyslipidemia in HIV"],"prefix":"10.1097","volume":"33","author":[{"given":"Sanjana","family":"Datla","sequence":"first","affiliation":[{"name":"University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH"},{"name":"University Hospitals Cleveland Medical Center, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Kumar","sequence":"additional","affiliation":[{"name":"University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH"},{"name":"University Hospitals Cleveland Medical Center, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"R1-20250203","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV.","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"R2-20250203","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.118.036211","article-title":"Time to recognize HIV infection as a major cardiovascular risk factor.","volume":"138","author":"Hsue","year":"2018","journal-title":"Circulation"},{"key":"R3-20250203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11904-016-0321-0","article-title":"Lipid abnormalities and inflammation in HIV inflection.","volume":"13","author":"Funderburg","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R4-20250203","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/gheg.2018.7","article-title":"HIV treatment is associated with a two-fold higher probability of raised triglycerides: pooled analyses in 21 023 individuals in sub-Saharan Africa.","volume":"3","author":"Ekoru","year":"2018","journal-title":"Glob Health Epidemiol Genom"},{"key":"R5-20250203","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/QAD.0000000000001837","article-title":"Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia.","volume":"32","author":"Leyes","year":"2018","journal-title":"AIDS"},{"key":"R6-20250203","first-page":"1423","article-title":"The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.","volume":"76","author":"Feingold","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20250203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2015.03.019","article-title":"High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis.","volume":"240","author":"D\u2019ascenzo","year":"2015","journal-title":"Atherosclerosis"},{"key":"R8-20250203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis.","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-20250203","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1097\/QAD.0000000000001633","article-title":"Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from an ongoing prospective cohort.","volume":"31","author":"Boccara","year":"2017","journal-title":"AIDS"},{"key":"R12-20250203","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.115.018531","article-title":"Circulating proprotein convertase subtilisin\/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors.","volume":"133","author":"Leander","year":"2016","journal-title":"Circulation"},{"key":"R13-20250203","doi-asserted-by":"crossref","first-page":"e009996","DOI":"10.1161\/JAHA.118.009996","article-title":"Coronary endothelial dysfunction is associated with elevated serum PCSK9 levels in people with HIV independent of low-density lipoprotein cholesterol.","volume":"7","author":"Leucker","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:02:03Z","timestamp":1738609323000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000587","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}